Literature DB >> 29095321

Burden of Seizure Clusters on Patients With Epilepsy and Caregivers: Survey of Patient, Caregiver, and Clinician Perspectives.

Patricia E Penovich1, Janice Buelow, Kathy Steinberg, Joseph Sirven, James Wheless.   

Abstract

OBJECTIVES: To characterize the burden of seizure clusters (SC) on patients and caregivers, a large internet-based survey was conducted.
METHODS: The Seizure Cluster Burden of Illness US Survey was conducted online by Harris Poll on behalf of The Epilepsy Foundation in September 2014. Respondents included adult patients 18 years and above with epilepsy or a seizure disorder who had experienced SC in the past year (defined as ≥2 seizures within 24 h outside the patient's typical seizure pattern), caregivers providing current care for a patient with SC (adult or child), and clinicians (neurologists, epileptologists) who treat adult or pediatric patients. Responses to a wide range of topics, including emotional well-being, daily function, productivity, and approach to clinical practice, were collected.
RESULTS: There were 861 respondents (259 adult SC patients, 263 caregivers, and 339 clinicians). A majority of all respondent groups felt SC have a moderate/major negative impact on patient and caregiver quality of life, including emotional, financial, and social components. Responses indicated possible overutilization of emergency room services and underutilization of rescue treatment. Only 30% of patients reported having a seizure emergency plan. Some responses showed discrepancies between clinicians and patients/caregivers in the perceived degree of negative impact of SC and management practices for SC.
CONCLUSIONS: These results suggest the need for increased education on managing SC. Clinicians need to develop seizure emergency plans and discuss rescue therapies, whereas patients and caregivers need to ask for and utilize these management strategies.

Entities:  

Mesh:

Year:  2017        PMID: 29095321     DOI: 10.1097/NRL.0000000000000140

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  10 in total

1.  Continuous seizure emergency evoked in mice with pharmacological, electrographic, and pathological features distinct from status epilepticus.

Authors:  Kevin M Knox; Dannielle K Zierath; H Steve White; Melissa Barker-Haliski
Journal:  Epilepsia       Date:  2021-10-08       Impact factor: 5.864

2.  Final results from a Phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy.

Authors:  James W Wheless; Ian Miller; R Edward Hogan; Dennis Dlugos; Victor Biton; Gregory D Cascino; Michael R Sperling; Kore Liow; Blanca Vazquez; Eric B Segal; Daniel Tarquinio; Weldon Mauney; Jay Desai; Adrian L Rabinowicz; Enrique Carrazana
Journal:  Epilepsia       Date:  2021-08-21       Impact factor: 6.740

3.  Bioavailability and Safety of a New Highly Concentrated Midazolam Nasal Spray Compared to Buccal and Intravenous Midazolam Treatment in Chinese Healthy Volunteers.

Authors:  Hui Wang; Jie Huang; Shuang Yang; Xing-Fei Zhang; Xiaoyan Yang; Chang Cui; Chan Zou; Li-E Li; Min Zhang; Miao-Fu Mao; Xiang Zhou; Kai-Ming Duan; Sai-Ying Wang; Guo-Ping Yang
Journal:  Neurol Ther       Date:  2022-02-07

4.  Seizure Clusters, Seizure Severity Markers, and SUDEP Risk.

Authors:  Manuela Ochoa-Urrea; Nuria Lacuey; Laura Vilella; Liang Zhu; Shirin Jamal-Omidi; M R Sandhya Rani; Johnson P Hampson; Mojtaba Dayyani; Jaison Hampson; Norma J Hupp; Shiqiang Tao; Rup K Sainju; Daniel Friedman; Maromi Nei; Catherine Scott; Luke Allen; Brian K Gehlbach; Victoria Reick-Mitrisin; Stephan Schuele; Jennifer Ogren; Ronald M Harper; Beate Diehl; Lisa M Bateman; Orrin Devinsky; George B Richerson; Guo-Qiang Zhang; Samden D Lhatoo
Journal:  Front Neurol       Date:  2021-02-12       Impact factor: 4.003

Review 5.  Seizure Clusters: Morbidity and Mortality.

Authors:  Kristie Bauman; Orrin Devinsky
Journal:  Front Neurol       Date:  2021-02-16       Impact factor: 4.003

6.  Effects of Vagus Nerve Stimulation on Sustained Seizure Clusters: A Case Report.

Authors:  Galih Ricci Muchamad; Ryosuke Hanaya; Shinsuke Maruyama; Chihiro Yonee; Hiroshi Hosoyama; Yusei Baba; Masanori Sato; Nozomi Sano; Toshiaki Otsubo; Koji Yoshimoto
Journal:  NMC Case Rep J       Date:  2021-04-29

Review 7.  Future opportunities for research in rescue treatments.

Authors:  James W Wheless; Daniel Friedman; Gregory L Krauss; Vikram R Rao; Michael R Sperling; Enrique Carrazana; Adrian L Rabinowicz
Journal:  Epilepsia       Date:  2022-09       Impact factor: 6.740

8.  Lack of clinically relevant differences in safety and pharmacokinetics after second-dose administration of intranasal diazepam within 4 h for acute treatment of seizure clusters: A population analysis.

Authors:  Gregory D Cascino; Daniel Tarquinio; James W Wheless; Robert Edward Hogan; Michael R Sperling; Jay Desai; Blanca Vazquez; Emil Samara; Sunita N Misra; Enrique Carrazana; Adrian L Rabinowicz
Journal:  Epilepsia       Date:  2022-04-19       Impact factor: 6.740

9.  Use of second doses of Valtoco® (diazepam nasal spray) across 24 hours after the initial dose for out-of-hospital seizure clusters: Results from a phase 3, open-label, repeat-dose safety study.

Authors:  Michael R Sperling; James W Wheless; R Edward Hogan; Dennis Dlugos; Gregory D Cascino; Kore Liow; Adrian L Rabinowicz; Enrique Carrazana
Journal:  Epilepsia       Date:  2022-02-02       Impact factor: 6.740

10.  Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters-a randomized, double-blind, placebo-controlled trial.

Authors:  Kamil Detyniecki; Peter J Van Ess; David J Sequeira; James W Wheless; Tze-Chiang Meng; William E Pullman
Journal:  Epilepsia       Date:  2019-05-29       Impact factor: 6.740

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.